Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Ruthenium-catalyzed oxidative Heck reactions.

Farrington EJ, Brown JM, Barnard CF, Rowsell E.

Angew Chem Int Ed Engl. 2002 Jan 4;41(1):169-71. No abstract available.

PMID:
12491475
2.

Metabolism, protein binding and in vivo activity of the oral platinum drug JM216 and its biotransformation products.

Raynaud FI, Boxall FE, Goddard P, Barnard CF, Murrer BA, Kelland LR.

Anticancer Res. 1996 Jul-Aug;16(4A):1857-62.

PMID:
8712713
3.

Studies on the Oral Anticancer Drug JM-216: Synthesis and Characterization of Isomers and Related Complexes.

Barnard CF, Vollano JF, Chaloner PA, Dewa SZ.

Inorg Chem. 1996 May 22;35(11):3280-3284.

PMID:
11666529
4.

Biotransformation of the platinum drug JM216 following oral administration to cancer patients.

Raynaud FI, Mistry P, Donaghue A, Poon GK, Kelland LR, Barnard CF, Murrer BA, Harrap KR.

Cancer Chemother Pharmacol. 1996;38(2):155-62.

PMID:
8616906
5.

Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.

Goddard PM, Orr RM, Valenti MR, Barnard CF, Murrer BA, Kelland LR, Harrap KR.

Anticancer Res. 1996 Jan-Feb;16(1):33-8.

PMID:
8615631
6.

Determination of metabolites of a novel platinum anticancer drug JM216 in human plasma ultrafiltrates.

Poon GK, Mistry P, Raynaud FI, Harrap KR, Murrer BA, Barnard CF.

J Pharm Biomed Anal. 1995 Nov;13(12):1493-8.

PMID:
8788134
7.

Metabolic studies of an orally active platinum anticancer drug by liquid chromatography-electrospray ionization mass spectrometry.

Poon GK, Raynaud FI, Mistry P, Odell DE, Kelland LR, Harrap KR, Barnard CF, Murrer BA.

J Chromatogr A. 1995 Sep 29;712(1):61-6.

PMID:
8556156
8.

DNA-binding properties of novel cis- and trans platinum-based anticancer agents in 2 human ovarian carcinoma cell lines.

Mellish KJ, Barnard CF, Murrer BA, Kelland LR.

Int J Cancer. 1995 Sep 15;62(6):717-23.

PMID:
7558420
9.

Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.

Kelland LR, Barnard CF, Evans IG, Murrer BA, Theobald BR, Wyer SB, Goddard PM, Jones M, Valenti M, Bryant A, et al.

J Med Chem. 1995 Aug 4;38(16):3016-24.

PMID:
7636864
10.

Bis(acetato)amminedichloro(cyclohexylamine)platinum(IV), an orally active anticancer drug.

Neidle S, Snook CF, Murrer BA, Barnard CF.

Acta Crystallogr C. 1995 May 15;51 ( Pt 5):822-4.

PMID:
7779322
11.

A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.

Kelland LR, Barnard CF, Mellish KJ, Jones M, Goddard PM, Valenti M, Bryant A, Murrer BA, Harrap KR.

Cancer Res. 1994 Nov 1;54(21):5618-22.

13.

Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.

Orr RM, O'Neill CF, Nicolson MC, Barnard CF, Murrer BA, Giandomenico CM, Vollano JF, Harrap KR.

Br J Cancer. 1994 Sep;70(3):415-20.

Supplemental Content

Loading ...
Support Center